Sophia Genetics (Sophia Genetics) Accounts Payable & Accrued Expense : $19.15 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sophia Genetics Accounts Payable & Accrued Expense?

Sophia Genetics's quarterly accounts payable & accrued expense declined from Sep. 2023 ($18.89 Mil) to Dec. 2023 ($9.62 Mil) but then increased from Dec. 2023 ($9.62 Mil) to Mar. 2024 ($19.15 Mil).

Sophia Genetics's annual accounts payable & accrued expense declined from Dec. 2021 ($13.56 Mil) to Dec. 2022 ($10.42 Mil) and declined from Dec. 2022 ($10.42 Mil) to Dec. 2023 ($9.62 Mil).

Sophia Genetics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Sophia Genetics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sophia Genetics Accounts Payable & Accrued Expense Chart

Sophia Genetics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

8.24

9.79

13.56

10.42

9.62

Sophia Genetics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial													18.13	20.35	18.89	9.62	19.15

Sophia Genetics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Sophia Genetics (Sophia Genetics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sophia Genetics SA (NAS:SOPH) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

90B:Germany

Address

Rue du Centre 172, Saint-Sulpice, CHE, CH-1025

Website

https://www.sophiagenetics.com

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities.